FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2530593005> ?p ?o ?g. }

• W2530593005 abstract "Over the past years, the survival of patients with Philadelphia-positive chronic myeloid leukemia (CML Ph(+)) has increased as a result of therapy with tyrosin kinase inhibitors (TKIs). Intolerance to TKIs has been described in approximately 20% of patients receiving treatment. We studied the incidence of imatinib intolerance in patients with CML Ph(+) and their outcome in our CML reference site, as there is no information about the evolution of patients intolerant to TKIs.A group of 86 patients with CML Ph(+) receiving imatinib monotherapy who abandoned treatment were the basis for this study. We present the trends of their disease evolution.The median of age at diagnosis was 42 years. Within a year, 19 (22%) of 86 patients developed imatinib intolerance, all of them with grade III or IV disease that required imatinib dose reduction or discontinuation. Of these patients, 16 (84%) of 19 developed transformation to blastic phase. The cumulative incidences of blastic phase development were 47% in the nonintolerant group and 84% in the intolerant group. There was a relative risk for those with imatinib intolerance to develop blastic phase of 1.78 (95% confidence interval, 1.28 to 2.42) (P < .05).Most imatinib-intolerant patients develop blastic phase transformation, with a poor survival of 3 to 6 months; no effective rescue treatment is available. Future research should to determine whether the origin of this evolution is really due to the intolerance itself or whether it is due to a more aggressive form of the disease, perhaps related to genetic transformation." @default.
• W2530593005 created "2016-10-21" @default.
• W2530593005 creator A5003723077 @default.
• W2530593005 creator A5007073972 @default.
• W2530593005 creator A5016369426 @default.
• W2530593005 creator A5021136864 @default.
• W2530593005 creator A5024269994 @default.
• W2530593005 date "2016-08-01" @default.
• W2530593005 modified "2023-09-25" @default.
• W2530593005 title "Imatinib Intolerance Is Associated With Blastic Phase Development in Philadelphia Chromosome–Positive Chronic Myeloid Leukemia" @default.
• W2530593005 cites W1527252739 @default.
• W2530593005 cites W1569913789 @default.
• W2530593005 cites W1966015047 @default.
• W2530593005 cites W1970962784 @default.
• W2530593005 cites W1972807372 @default.
• W2530593005 cites W2005726906 @default.
• W2530593005 cites W2019248167 @default.
• W2530593005 cites W2028959752 @default.
• W2530593005 cites W2033978323 @default.
• W2530593005 cites W2053310263 @default.
• W2530593005 cites W2057718276 @default.
• W2530593005 cites W2058576674 @default.
• W2530593005 cites W2066099870 @default.
• W2530593005 cites W2071686284 @default.
• W2530593005 cites W2079446921 @default.
• W2530593005 cites W2080060037 @default.
• W2530593005 cites W2080125373 @default.
• W2530593005 cites W2107268345 @default.
• W2530593005 cites W2129382787 @default.
• W2530593005 cites W2144770959 @default.
• W2530593005 cites W2145480759 @default.
• W2530593005 cites W2147124043 @default.
• W2530593005 cites W2148371819 @default.
• W2530593005 cites W2153787194 @default.
• W2530593005 cites W2413268903 @default.
• W2530593005 cites W2473786944 @default.
• W2530593005 cites W3151598270 @default.
• W2530593005 cites W2093802609 @default.
• W2530593005 doi "https://doi.org/10.1016/j.clml.2016.02.028" @default.
• W2530593005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27521331" @default.
• W2530593005 hasPublicationYear "2016" @default.
• W2530593005 type Work @default.
• W2530593005 sameAs 2530593005 @default.
• W2530593005 citedByCount "5" @default.
• W2530593005 countsByYear W25305930052017 @default.
• W2530593005 countsByYear W25305930052020 @default.
• W2530593005 countsByYear W25305930052022 @default.
• W2530593005 crossrefType "journal-article" @default.
• W2530593005 hasAuthorship W2530593005A5003723077 @default.
• W2530593005 hasAuthorship W2530593005A5007073972 @default.
• W2530593005 hasAuthorship W2530593005A5016369426 @default.
• W2530593005 hasAuthorship W2530593005A5021136864 @default.
• W2530593005 hasAuthorship W2530593005A5024269994 @default.
• W2530593005 hasConcept C104317684 @default.
• W2530593005 hasConcept C120665830 @default.
• W2530593005 hasConcept C121332964 @default.
• W2530593005 hasConcept C126322002 @default.
• W2530593005 hasConcept C138626823 @default.
• W2530593005 hasConcept C185592680 @default.
• W2530593005 hasConcept C2777583451 @default.
• W2530593005 hasConcept C2778715236 @default.
• W2530593005 hasConcept C2778729363 @default.
• W2530593005 hasConcept C2778904597 @default.
• W2530593005 hasConcept C2779134260 @default.
• W2530593005 hasConcept C2911091166 @default.
• W2530593005 hasConcept C3019892230 @default.
• W2530593005 hasConcept C55493867 @default.
• W2530593005 hasConcept C61511704 @default.
• W2530593005 hasConcept C71924100 @default.
• W2530593005 hasConcept C88879693 @default.
• W2530593005 hasConcept C90924648 @default.
• W2530593005 hasConceptScore W2530593005C104317684 @default.
• W2530593005 hasConceptScore W2530593005C120665830 @default.
• W2530593005 hasConceptScore W2530593005C121332964 @default.
• W2530593005 hasConceptScore W2530593005C126322002 @default.
• W2530593005 hasConceptScore W2530593005C138626823 @default.
• W2530593005 hasConceptScore W2530593005C185592680 @default.
• W2530593005 hasConceptScore W2530593005C2777583451 @default.
• W2530593005 hasConceptScore W2530593005C2778715236 @default.
• W2530593005 hasConceptScore W2530593005C2778729363 @default.
• W2530593005 hasConceptScore W2530593005C2778904597 @default.
• W2530593005 hasConceptScore W2530593005C2779134260 @default.
• W2530593005 hasConceptScore W2530593005C2911091166 @default.
• W2530593005 hasConceptScore W2530593005C3019892230 @default.
• W2530593005 hasConceptScore W2530593005C55493867 @default.
• W2530593005 hasConceptScore W2530593005C61511704 @default.
• W2530593005 hasConceptScore W2530593005C71924100 @default.
• W2530593005 hasConceptScore W2530593005C88879693 @default.
• W2530593005 hasConceptScore W2530593005C90924648 @default.
• W2530593005 hasLocation W25305930051 @default.
• W2530593005 hasLocation W25305930052 @default.
• W2530593005 hasOpenAccess W2530593005 @default.
• W2530593005 hasPrimaryLocation W25305930051 @default.
• W2530593005 hasRelatedWork W1975932664 @default.
• W2530593005 hasRelatedWork W200197067 @default.
• W2530593005 hasRelatedWork W2025600767 @default.
• W2530593005 hasRelatedWork W2045023664 @default.
• W2530593005 hasRelatedWork W2095846263 @default.
• W2530593005 hasRelatedWork W2134512113 @default.
• W2530593005 hasRelatedWork W2188180571 @default.

• next